Thursday, September 10, 2009
One dose should do it...
There are a number of novel H1N1 articles, and an editorial, now available online from the New England Journal of Medicine. The one you will be hearing about on CNN is this one, which demonstrates that a single 15 microgram dose of the non-adjuvanted vaccine produces protective antibody titers in over 95% of healthy adults (aged 18-64). There are a few caveats about the trial that are covered in the accompanying editorial, including that it was conducted in Australia while the novel H1N1 was circulating. But overall, the study is reassuring—it will be a lot easier to roll out this vaccine if only one dose is needed for most adults. Whether this holds up in kids, the elderly, and the immunocompromised remains to be seen.
Subscribe to:
Post Comments (Atom)
OSHA! OSHA! OSHA!
In many parts of the country, as rates of COVID-19 are declining and vaccination coverage is increasing (albeit with substantial variati...
-
In many parts of the country, as rates of COVID-19 are declining and vaccination coverage is increasing (albeit with substantial variati... -
This is a guest post by Jorge Salinas, MD, Hospital Epidemiologist at the University of Iowa Hospitals & Clinics. There is virtually no...
-
I’m surprised that we can’t stop arguing about the modes of SARS-CoV-2 transmission, despite the fact that most experts (including our frie...
No comments:
Post a Comment
Thanks for submitting your comment to the Controversies blog. To reduce spam, all comments will be reviewed by the blog moderator prior to publishing. However, all legitimate comments will be published, whether they agree with or oppose the content of the post.